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Upper extremity digital subtraction venography with gadoter- veins used to carry out fistulas are mainly the superficial
ate meglumine before fistula creation for hemodialysis. veins of the forearm and the arm. The surgeon chooses
Background. The purpose of this study was to evaluate the the appropriate vein after a physical examination withfeasibility, safety, and potential role of gadoterate meglumine
a tourniquet. However, after years of renal insufficiency(Gd-DOTA) as a contrast agent for upper extremity venogra-
requiring repeated blood samples, the venous system isphy before the creation of an arteriovenous fistula (AVF) for
nondialyzed renal insufficiency patients. often damaged and its physical examination may present
Methods. Over a 16-month period, 50 venographies were difficulties, especially in cases of obesity. Mapping the
performed on end-stage renal insufficiency patients, using Gd- venous system is then necessary to help identify whichDOTA as a contrast agent on a high-resolution digital subtrac-
vein should be used in order to provide an effective andtion angiography system. Three sequences were performed on
lasting AVF [2].forearm, arm, and chest at 3 mL/sec for a total of 35 mL of
Gd-DOTA. Examinations were reviewed by two radiologists Conventional or digital subtraction venography is con-
for diagnostic and opacification quality. Tolerance was evalu- sidered to be the standard of reference for assessment
ated on the evolution of serum creatinine levels and occurrence of the venous system [3]. It is performed with iodinatedof pain during injection.
contrast agents if the patient is already dialyzed (perito-Results. Good interobserver correlation was obtained in
neal dialysis or temporary venous catheters). However,evaluating the feasibility of AVF creation by vein segment
(0.64 , k , 0.88) and in relationship to opacification quality because of the time necessary for their development
(0.62 to 0.87). No deterioration in renal function (creatinine (approximately one month but this is highly variable),
level before and after) or pain was observed. Twenty-six pa-
fistulas should be created before terminal renal insuffi-tients underwent surgical creation of brachiobasilic (N 5 8),
ciency. For such patients, venography with iodinatedbrachiocephalic (N 5 8), radiocephalic (N 5 8), and cubito-
cephalic (N 5 1) fistulas or insertion of a polytetrafluoroethy- contrast agents carries a high risk of temporary or even
lene (PTFE) graft (N 5 1). Seventeen were awaiting AVF or permanent deterioration in renal function, leading to
were on peritoneal dialysis. Two died before surgery for rea- premature dialysis in these patients, resulting in an in-
sons unconnected with the venography.
creased cost in their treatment. The principal risk factorConclusions. Venography with Gd-DOTA is an effective
of nephrotoxicity with iodinated contrast agents is a pre-and safe technique in planning AVFs for renal insufficiency
patients. existing azotemia [4–6], with this risk increased in associ-
ated cases of diabetes [6, 7]. Therefore, a non-nephro-
toxic contrast agent would be very useful to limit the
Arteriovenous fistulas (AVF) are the best mode of occurrence of contrast medium–induced acute renal failure.
vascular access for hemodialysis in patients with end- Gadolinium chelates have proved to be safe, well-
stage renal disease [1]. The radiocephalic (brescia-cimino) tolerated, and effective contrast agents and have been
fistula is considered to have the greatest longevity. The assessed as less nephrotoxic than iodinated contrast agents
[8–10]. In patients with renal insufficiency, an intrave-
nous injection of gadopentate dimeglumine (Gd-DTPA)Key words: renal insufficiency, vascular access, contrast agent, arterio-
venous fistula, dialysis access. has not shown any evidence of nephrotoxicity during
magnetic resonance (MR) imaging with doses as large asReceived for publication May 5, 2000
0.4 mmol/kg [8, 9]. Since 1989, on the basis of theoreticaland in revised form October 6, 2000
Accepted for publication October 12, 2000 considerations, gadolinium has been used in patients who
are allergic to iodinated contrast media as an alternativeÓ 2001 by the International Society of Nephrology
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Fig. 2. Digital subtraction venography of the left arm performed with
8 mL of Gd-DOTA. Contrast density is adequate. The cephalic and
basilic veins are readily identified. Confirmation of the correct filling
Fig. 1. Digital subtraction venography of the left forearm performed of the terminal part of the cephalic vein at the level of elbow.
with 8 mL of gadoterate meglumine (Gd-DOTA) shows an adequately
sized cephalic vein from his median part, whereas the basilic vein is
small. Note that the last part of the cephalic vein seems to have a stenosis
with correct filling on next images (see Fig. 2). Surgical performance of the two examinations; 40 patients had a unilateral exami-a radiocephalic fistula on medium part of the forearm with a good
nation, thus forming a total of 50 upper limbs examined.evolution after one month.
Only two patients had also undergone a venography with
CO2 as a contrast agent prior to referral to our center.
However, these venographies were considered insuffi-
x-ray contrast agent initially for computed tomography cient to identify the vein to be anastomosed because of a
[10, 11] and subsequently for digital subtraction angiog- poor filling of the veins. Three patients were hemiplegic,
raphy [12–14]. It has also been proposed as a contrast rendering the realization and the interpretation of the
agent for various types of interventional procedures in images more difficult.
patients with renal insufficiency [15, 16].
Imaging techniquesThe aim of our study was to evaluate the feasibility,
safety, and potential role of gadoterate meglumine (Gd- The venographies were performed on a high-resolu-
DOTA; DOTAREMt; Guerbet Laboratories, Aulnay- tion digital subtraction system (Multistar T.O.P.; Sie-
sous-Bois, France) as a contrast agent for upper extremity mens A.G., Erlangen, Germany) after puncture of a dor-
venography before the creation of an AVF. Gadolinium sal vein in the hand with a 21-gauge needle, preferably
chelates have been used to perform digital subtraction on the radial side. The upper limb examined was immobi-
inferior vena cavography in patients with renal insuffi- lized through supination and abduction at 458. Three suc-
ciency [17], but to our knowledge, this is the first large cessive sequences were performed on the forearm (Fig.
study using gadolinium chelates for this purpose. 1), the arm (Fig. 2), and the thorax, including the superior
vena cava (Fig. 3), with digitalized images obtained with
the same technical parameters as those used for the ven-METHODS
ography with iodinated contrast agents: 96 kVp, 6 to
Patients 25 mA, a sequence of three images per second, a matrix
This retrospective study was carried out between April of 1024 3 1024, and a field size of 40 cm. The first 10
1998 and September 1999. Forty-five patients (22 males examinations of our study were performed using the
and 23 females) with an average age of 62 6 14 (range bolus-chasing technique, where only images of the initial
of 26 to 88), whose clinical examinations proved incon- segment opaqued, that is, the forearm, were subtracted.
clusive—approximately one third of all patients requir- The following images were acquired during the move-
ing an AVF in our center—underwent upper extremity ment of the table, and no “mask” could be obtained.
venography before creation of an AVF. All patients were We then modified the protocol of opacification because
renal insufficient pending dialysis with an average creati- the best results were obtained with this technique. The
nine serum level of 545 6 264 mmol/L (range of 262 to following 40 examinations were therefore performed
1360). In view of the restrictions in terms of quantity, with three sequential subtracted acquisitions, succes-
that is, the total dose of gadolinium chelates must not sively including the forearm, the arm, and the thorax.
exceed 0.6 mL/kg or 0.3 mmol/kg, the examination was Each step of this technique was performed without any
unilateral and performed preferably on the side of the movement of the table. The first digital images of one
nondominant upper limb. series were acquired just before the injection and consti-
Five patients had a bilateral examination of their up- tuted the “mask” that could be subtracted from the
opaqued images.per limbs, with a difference of at least three days between
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basilic veins of the forearm and arm and the capacity of
the vein to create a fistula. The medial antebrachial vein
was not examined as it is not used to create AVF. The
veins were graded from one (insufficient visualization)
to three (good visualization) for the opacification quality
and from one (AVF impossible) to three (AVF possible)
for the AVF-creation diagnosis. This diagnosis was based
on the analysis of the diameter of the vein (a minimum
diameter of 3 mm was usually required by our surgeons)
and its uniformity (absence of stenosis). Subclavian
veins, innominate veins, and the vena cava superior were
graded for their opacification quality according to the
same range from one to three and for the stenosis diagno-
sis. The vascular radiology images of the same patient
were present in a random manner; thus, the images were
not seen in a sequence, except by chance. The patients’
names were obscured from the raters. The interobserver
correlation was evaluated using the correlation coeffi-Fig. 3. Digital subtraction venography of the vena cava superior per-
formed with 16 mL of Gd-DOTA also allows to evidence innominate cient Cohen’s kappa (k) [18]. The correlation was calcu-
and subclavian veins. lated vein by vein for the diagnosis and for the quality
of opacification.
Tolerance analysis
We used the same automatic injector (Mark V Plus;
Serum creatinine levels before and after the examina-Medrad, Philadelphia, PA, USA) as that used for iodine
tion were measured, as that seems to be the most efficientduring vascular examinations. Undiluted Gd-DOTA was
and least costly biological criteria to evaluate the renalinjected at a volume of 8 mL for the first two sequences
function [6]. In four cases, the creatinine levels could notand 16 mL on the thorax, at a 3 mL/sec rate of injection.
be used, as the second measurement took place too late
The technical key to success is the use of a low-resistance
after the examination. The most commonly used definition
extension tubing set commonly used for gadolinium-
in the literature for renal failure was used: an increase of
enhanced MR imaging (150 cm length, 3.0 mm lumen more than 20% of the serum creatinine levels 48 to 72
diameter, 4.1 mm external diameter; Codan GmbH, Len- hours after the examination [4]. A variation of the ratio
sahn, Germany) containing a total volume of 8 mL. The [(creatinineafter 2 creatininebefore)/creatininebefore] 3 100 ex-contrast agent was inserted in advance using a three-way pressed as a percentage was judged more appropriate
stopcock to fill the extension tubing set. One extension for our group of patients with high levels of creatinine,
tubing set was filled with 8 mL for the opacification on rather than the rise of the creatinine level alone. There
the arm and the forearm. An additional extension tubing was no protocoled hyperhydration nor fasting performed
set was connected to the first one and also filled with in relationship to the examination. Discomfort expressed
8 mL for the thoracic opacification. The injector pulsed by the patient during the gadolinium chelate injection
gadolinium with 20 mL of saline for the first two se- was noted by the radiologist performing the examination.
quences and 40 mL of saline for the thorax.
The total injection did not exceed 35 mL Gd-DOTA,
RESULTSwhich in relationship to the body weight of the patients
corresponded to less than 0.6 mL/kg or 0.3 mmol/kg of Diagnosis and opacification quality
gadolinium chelate. A tourniquet was placed above the Good interobserver correlation was identified for the
elbow during the sequence on the forearm and on the diagnosis of feasibility of fistulas by vein segment, with
proximal segment of the arm during the sequence on k indexes greater than 0.60: cephalic vein of the forearm
the arm to allow an optimal opacification of the superfi- (k 5 0.65), cephalic vein of the arm (k 5 0.88), basilic
cial and deep veins. vein of the forearm (k 5 0.72), and basilic vein of the
arm (k 5 0.64). There was also a good correlation be-
Image analysis tween the observers to grade the opacification quality
Subtracted and unsubtracted images from the same with indexes between k 5 0.62 and k 5 0.87 (Table 1).
patients were interpreted by two radiologists (O.G. and As the period of rating improvement in relationship
M.T.) in an independent manner. They were instructed with the improvement of the operator’s experience was
not included in this study, no learning curve was notedto grade the quality of opacification of the cephalic and
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Table 1. Interobserver grading of quality opacification of 50 Gd- Renal. There was no impairment of the renal function
DOTA venographies
for any of those patients in end-stage renal insufficiency.
Extremity Mean Range The average level of serum creatinine increased slightly
Forearm from 545 6 264 mmol/L (range of 262 to 1360) to 550 6
Basilic vein 0.84 0.68–1.00 250 mmol/L (range of 223 to 1270) after the examination,
Cephalic vein 0.84 0.68–1.00
for an average nonsignificant increase of 3%. The indi-Arm
Basilic vein 0.73 0.59–0.87 vidual variations ranged from 219 to 12%, and no pa-
Cephalic vein 0.87 0.76–0.98 tient’s serum creatinine level increased by more than 20%.
Thorax
Subclavian vein 0.83 0.67–0.99
Surgical dataInnominate vein 0.74 0.62–0.86
Vena cava superior 0.62 0.44–0.80 Surgical data were available for 26 patients; 17 patients
Values of the k coefficient are according to the upper extremity segment. currently are awaiting AVF or on peritoneal dialysis.
Two patients died before the creation of an AVF for
reasons not connected with the venography. The surgery
consisted of the creation of brachio-basilic fistulas for
during the rating of the examinations. As subtracted and
eight patients, brachio-cephalic fistulas for eight patients,
unsubtracted images of one patient were simultaneously
and radio-cephalic fistulas for eight patients. One patient
interpreted, the grading used did not aim to analyze the underwent a cubito-cephalic fistula and another under-
difference in opacification quality of both types. How- went an insertion of a polytetrafluoroethylene (PTFE)
ever, subtracted high-definition images are known to offer graft between the artery and the brachial vein. In one
the highest contrast and facilitate the interpretation. case, although a cephalic vein was identified in the fore-
The opacification quality allowed visualization of the arm through venography, no radiocephalic fistula was
veins of the forearm the arm and the subclavian vein, performed because of an occlusion of the radial artery;
which had been graded as good by the two raters in the surgical intervention then consisted of a brachio-
more than 75% of cases. A significant stenosis of the cephalic fistula. Preoperative clinical evaluation of the
subclavian vein was assessed in one patient and occlusion veins by the surgeon was difficult because of their poor
of the innominate and subclavian veins was evidenced status, and the choice of the surgical technique was there-
in another. Out of 50 examinations, 33 identified a ce- fore based on venography. We followed the evolution
phalic vein of the forearm that could allow the creation of these fistulas in 24 cases. The evolution after one
of a radiocephalic AVF, widely considered by surgeons month was normal with 23 operational fistulas. Only one
to be the first preferred intention option. As the popula- radio-cephalic fistula did not develop properly initially,
tion studied had a poor venous status with inconclusive but presented normal development after angioplasty of
clinical examinations, venography helped to optimize the an arterial stenosis.
best choice of the AVF type for optimum reliability and
longevity.
DISCUSSIONA decrease of contrast was noted in the innominate
veins and in the superior vena cava due to x-ray attenua- Feasibility and reliability
tion through tissue, combined with respiratory motion. Gadolinium has an atomic number of 64 and a
The contrast agent present in one of the innominate k-absorption edge of 50 keV quite similar to that of iodine
veins was also diluted by the contralateral vein. (atomic number 5 53; k-absorption edge 5 33 keV).
Visualization of the thoracic veins markedly increased Gadolinium-based contrast agents have shown that they
when the bolus-chasing technique (N 5 10, 33% of “in- absorb sufficient energy to be visualized during angiogra-
sufficient” grades) was replaced by a sequential sub- phy by digital subtraction. Quinn et al found that use of
tracted acquisition technique (N 5 40, 10% of “insuffi- gadopentetate dimeglumine resulted in attenuation 2.5
cient” grades). times greater than that with equimolar concentrations
of iopromide, an iodinated contrast agent, at 120 kVp
Tolerance and 150 mA [11]. Despite the theoretically favorable
Clinical. No warm sensation nor allergic reaction was x-ray imaging properties of gadolinium-based contrast
notified for any of the examinations. One case of extrava- agent, the actual vascular enhancement observed during
sation of approximately 5 mL was reported, with no com- digital subtraction angiography was weaker than that
plications after three weeks of clinical supervision. The observed with iodinated contrast agents. This is because
examination was considered substantially less painful of the relatively low (semimolar) concentration of gado-
than the injection of carbon dioxide gas by the two patients linium in currently available MR imaging contrast agents.
who had a prior CO2 venography. One case of vomiting Good interobserver correlation has been observed to
evaluate the opacification quality and to diagnose thewas reported in a patient during the examination.
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possibility of AVF creation. The opacification quality is Sullivan et al found upon initial analysis that carbon
dioxide (CO2) venography could be recommended ingood for the veins of the forearm and the arm, which
provides better reliability of the surgeon’s preopera- cases of contraindication to iodine [24], but this contrast
agent causes pain during venous injections [23], overesti-tional selection of the vein to be used, thereby avoiding
early thrombosis or malfunctioning of the fistulas [19]. mates stenosis [24, 25], and can lead to serious complica-
tions [26, 27], in particular a potential risk of pulmonaryIn practice, it is indispensable to use digital subtraction
to produce informative images. A venography protocol embolism in this indication. Furthermore, although its
cost is substantially lower than that of gadolinium che-using successive series allowing subtraction during all
sequences improves the visualization of the veins of the lates, it requires a costly injector (specific for gas),
whereas gadolinium is injected using the regular injectorarm and the forearm, and appeared to be preferable to
the bolus-chasing technique we used at the beginning of for iodinated contrast agents.
Carbon dioxide may also be injected by hand by usingour experience. We abandoned this initial technique as
the reduction in quantity of the gadolinium was counter- a bag delivery system [28], but Hawkins and Caridi
strongly recommend not using hand injection directlybalanced by the decrease in the quality of opacification.
The opacification of the thoracic veins appeared of a from the CO2 cylinder since air contamination can
readily occur, and explosive delivery or excessive vol-lesser quality. The optimization of the injection parame-
ters (16 mL to 3 mL/sec), injection pulsed by saline, and umes are more difficult to control [29].
Carbon dioxide appears to provide high-quality im-the most appropriate choice of mask allowed us to obtain
sufficient opacification. However, opacification of central ages in the intrathoracic veins in which gadolinium seems
to be a weaker contrast agent at the doses used. How-veins remains problematic. Strategies to improve visual-
ization could consist of increasing the volume of the ever, although these contrast agents may appear comple-
mentary, CO2 injections on the other hand expose pa-contrast agent (for example, 20 to 25 mL Gd-DOTA
rather than 16 mL for thoracic opacification while still tients to severe complications.
(1) Carbon dioxide should not be used for cerebralmaintaining a reasonable limit on total dose of gadolin-
ium), elevation of the extremity to improve flow, and arterial circulation. This product is contraindicated for
intra-arterial supradiaphragmatic injection with a risksqueezing the forearm to “milk” contrast medium into
the central veins allows to evidence innominate and sub- of brain gas embolism caused by air-block phenomena
[29, 30]. After injection of CO2 to control an AVF withclavian veins.
With regard to the results from the thoracic imaging countercurrent reflux in the artery, among five patients,
two experienced seizures and another one experiencedpart of the study, we could consider that patients with
a history of central venous catheterism, especially of the loss of consciousness with a 30-second respiratory arrest
[31]. Although no cases of neurologic complications havesubclavian variety [20], should undergo a complementary
thoracic MR angiography to evaluate the subclavian vein been reported in patients with cardiac septal defects,
CO2 should not be used in the venous circulation ofin case of weak opacification just after the venography:
No reinjection is necessary because of the renal insuffi- patients suspected to have a right to left intracardiac
shunt [29, 30]. In the interest of patient’s safety, a possibleciency. However, if a small additional volume of gadolin-
ium is sufficient to evaluate the thoracic veins, it would cardiac septal defect should be detected when an intrave-
nous injection of CO2 is planned. This is not the case forbe more economical.
Despite the good interobserver correlation, clinical Gadolinium chelates, which have been used as alterna-
tive contrast agent for direct carotid angiography withoutproof and follow-up data are deemed to be the best
methods for evaluating a diagnostical method [21]. It any neurotoxicity [32].
(2) There is also a risk of acute heart failure causedshould be emphasized that all of the patients benefited
from the surgical performance of an AVF based only by gas trapping in the right cavities [29, 30]. Excessive
volumes can flood the right side of the heart, leading toon the data from gadolinium venography, with a good
evolution. pump failure. Three transient cardiac arrests have been
related in the literature [29]. This risk increases whenTolerance of gadolinium used for MR imaging exami-
nations is now well established, with a level of side effects CO2 is injected to the veins rather than the arteries be-
cause of the buoyancy of CO2. Volumes should not ex-of 2.4%, 94% of which are minor [22]. In our study,
patients had no warm sensations or allergy, allowing ceed 100 mL in arteries and 50 mL in veins [30], and a
time interval between two injections must be respected.routine use without them having to fast. There was no
deterioration of the renal function during our study with In our experience, the two patients whose CO2 venog-
raphy was deemed insufficient because of insufficienttotal doses of less than 0.3 mmol/kg (0.6 mL/kg) adminis-
tered, confirming the data found in the literature. This opacification of the veins of the forearm successfully
underwent AVF on the basis of the gadolinium venogra-absence of nephrotoxicity was observed for doses up to
0.4 mmol/kg [8]. phy data.
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